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Abstract
The centrality of quality as a strategy to achieve impact within the U.S. President’s Emergency 
Plan for AIDS Relief (PEPFAR) has been widely recognized. However, monitoring program 
quality remains a challenge for many HIV programs, particularly those in resource-limited 
settings, where human resource constraints and weaker health systems can pose formidable 
barriers to data collection and interpretation. We describe the practicalities of monitoring quality at 
scale within a very large multicountry PEPFAR-funded program, based largely at health facilities. 
The key elements include the following: supporting national programs and strategies; developing a 
conceptual framework and programmatic model to define quality and guide the provision of high-
quality services; attending to program context, as well as program outcomes; leveraging existing 
and routinely collected data whenever possible; developing additional indicators for judicious use 
in targeted, in-depth assessments; providing hands-on support for data collection and use at the 
facility, sub-national, and national levels; utilizing web-based databases for data entry, analysis, 
and dissemination; and multidisciplinary support from a large team of clinical and strategic 
information advisors.
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The quality of health services drives both utilization and outcomes, and is an essential 
component of effective and efficient health systems [1]. In the context of HIV programs, 
high-quality treatment of people living with HIV (PLWH) leads not only to decreased 
morbidity and mortality but also to decreased transmission of HIV to others [2]; achieving 
broad coverage with high-quality HIV services is a key element of epidemic control.
The importance of enhancing program quality to achieve impact against HIV has been 
emphasized by diverse national and international agencies, and an increasing number of 
countries now have national HIV quality strategies, including Tanzania, Kenya, and Haiti – 
all profiled in this Supplement. Quality assurance, including defining quality, setting 
standards, and developing performance indicators, is a critical step towards identifying and 
addressing quality deficits. Implementing quality assurance remains an important challenge 
for HIV programs, particularly those in resource-limited settings, where human resource 
constraints and weaker health systems can pose formidable barriers to data collection and 
interpretation [3]. Quality improvement is a second key component of quality management, 
and building site-level and program-level capacity to identify quality barriers and to rapidly 
test interventions is a high priority in many countries.
We describe the practicalities of monitoring quality at scale within a large multicountry 
program funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), and 
describe a country-specific case study from Kenya. ICAP at Columbia University has been a 
PEPFAR implementing partner since 2004, and has supported more than 4000 health 
facilities in 15 countries to implement HIV prevention, care, and treatment services. Over 
the past decade, ICAP has supported the enrollment of 2.3 million adults and children in 
HIV care, and the initiation of 1.4 million people on antiretroviral therapy (ART). Working 
hand in hand with national governments and local partners, ICAP supports a wide range of 
complex HIV and health programs, including those targeting HIV prevention, HIV 
diagnosis, prevention of mother-to-child transmission (PMTCT), care and treatment of 
adults, adolescents and children, HIV services for key populations [including men who have 
sex with men (MSM), people who inject drugs, sex workers, prisoners, and migrant and 
displaced populations], tuberculosis (TB), malaria, noncommunicable diseases, reproductive 
health, and maternal/child health. In all of its programs, ICAP works to strengthen health 
systems, to build capacity of healthcare workers and program managers, and to support 
national policies, strategies, and guidelines.
Drawing on its years of experience supporting the design, implementation, evaluation, and 
analysis of HIV programs in low-resource settings, as well as resources from national 
partners, PEPFAR, and multilateral agencies, ICAP has developed an approach to quality 
management that includes both quality assurance and quality improvement. Quality 
assurance – the focus of this article – starts with ICAP’s ‘Model of Care’, which is a quality 
framework characterized by the delivery of comprehensive, integrated, family-focused 
services along the HIV prevention and care continuum for adults, adolescents, children, and 
pregnant women. This model defines a comprehensive ‘Package of Care’ for PLWH, 
encompassing the full continuum of HIV care, including: linkage to health services for 
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people testing positive for HIV; support for retention in care; provision of appropriate 
clinical and laboratory monitoring; prompt initiation of ART for eligible patients; ongoing 
adherence support; and services to enhance psychosocial well being and secondary 
prevention of HIV [4].
Within this comprehensive package, ICAP highlights 10 ‘Core Interventions’ – domains that 
should be available at all health facilities (Table 1). These evidence-based interventions were 
selected on the basis of their impact on incidence, morbidity and mortality, and each 
includes multiple components. ICAP programs are not limited to the Core Interventions; 
additional services are provided as needed within specific countries and contexts. For 
example, country programs are responsive to national epidemics, providing appropriate 
interventions targeted at local key populations, such as MSM and/or people who inject 
drugs.
Once Core Interventions were defined, ICAP developed a strategy to routinely measure and 
monitor program quality across all ICAP-supported health facilities, mapping indicators to 
Core Interventions and their key components while minimizing the collection of extraneous 
data. This approach to quality assurance, which leverages existing and routinely collected 
data as much as possible, is described below.
Methods
ICAP assesses the extent to which the Core Interventions are implemented across 15 
countries and thousands of health facilities, utilizing routinely collected PEPFAR indicators 
that allow comparisons over time and across countries. In addition, ICAP developed 
program-specific indicators [‘Standards of Care’ (SOC)] for targeted, in-depth assessment of 
quality, and periodic health facility surveys (’PFaCTs’ or Program and Facility 
Characteristics Tracking Systems) to describe and monitor facility-level services, 
infrastructure, context, and capacity. Whenever possible, ICAP uses existing national tools 
and systems to monitor the program quality.
Routinely collected PEPFAR indicators
PEPFAR indicators are designed by the US Office of the Global AIDS Coordinator (OGAC) 
to be efficient and practical, and to meet the U.S. government’s (USG’s) minimum needs in 
demonstrating progress towards its key legislative goals: treatment of six million people; 
80% coverage of HIV testing and counseling among pregnant women; 85% coverage of 
antiretroviral prophylaxis for HIV-positive pregnant women; care for 12 million people; and 
professional training for 140 000 healthcare workers (www.pepfar.gov). As a PEPFAR-
implementing partner, ICAP collects a standard set of programmatic indicators for all of its 
programs and health facilities, and reports these quarterly to USG agency country offices.
PEPFAR indicators have evolved over time; the latest set includes 61 major indicators, many 
of which are also disaggregated by patient age and sex [5]. In addition to submitting these 
indicators to USG agency country offices, each ICAP country team submits 30 indicators – a 
subset of the 61 major indicators – to ICAP headquarters on a quarterly basis via a web-
based reporting and dissemination tool called the ICAP Unified Reporting System (URS) 
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(see below). Twenty-one of these 30 indicators map to ICAP’s Core Interventions and their 
key components, and ICAP teams use these 21 ‘Priority Indicators’ for quality assessment 
purposes. ICAP established targets for these Priority Indicators against which all country 
programs assess their achievements (Table 2).
Each ICAP-supported health facility submits an average of 200 data elements [interquartile 
range (IQR) 28–227] for the 30 indicators, including data stratified by age, sex, and points of 
service, requiring approximately 700 000 data points to be submitted, verified, collated, and 
summarized every quarter from nearly 3400 health facilities. Accurate and timely collection 
of these data to facilitate effective monitoring of program quality requires intense and 
ongoing work by a large team of approximately 180 data collectors, informatics, and 
strategic information experts. The median size of the ICAP country office Strategic 
Information teams is 13 people (IQR 7–20), supported by a headquarters team of 15 staff 
members with expertise in monitoring and evaluation (M&E), epidemiology, data analysis, 
and surveillance.
Data collection
To collect and manage this large volume of data every quarter, ICAP provides technical 
assistance and hands-on support to health facilities as they implement the national 
standardized monthly summary forms developed by Ministries of Health (MoH). ICAP 
clinical and M&E advisors provide routine supportive supervision on a monthly to quarterly 
basis to health facility staff to use these forms to report on performance on a monthly basis. 
Data from standardized registers, appointment log books, and patient treatment cards are 
summarized on these forms and sent to the district and provincial health offices for 
aggregation, as illustrated in the case study from Kenya below.
In several countries, including Kenya, the MoH uses an open source database program called 
the District Health Information Software (DHIS2) (https://www.dhis2.org/) to aggregate data 
from facilities at district, province, and national levels. In six country programs, ICAP uses 
DHIS2 to store performance data for supported facilities, so as to harmonize with MoH 
DHIS2 databases. ICAP also actively supports MoH to adopt and implement national 
database platforms to streamline data management and promote data use by program 
managers. For example, ICAP is currently supporting the MoH in Lesotho to implement an 
ambitious plan to build a national data warehouse for all health data in a web-based DHIS2 
platform. This initiative will harmonize data currently collected via disparate legacy systems 
that are not linked or interoperable.
To ensure that assessment of program quality is based on high-quality data, ICAP country 
offices also conduct regular data quality assurance (DQA) exercises using a standard 
approach, selecting a random sample of patient files, and comparing completeness and 
consistency across various data sources, including registers, monthly summary forms, and 
facility-based or ICAP country databases. Each country sets targets for completeness and 
accuracy, and monitors facility performance on data quality over time. Data quality 
generally improves over time as facilities receive continued, on-site mentoring from ICAP 
advisors and gain experience in completing and reviewing data.
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In 2005, ICAP developed a database platform called the Unified Reporting System (URS) to 
collect, archive, and disseminate aggregate program data. The URS is designed to help keep 
track of sites, indicators, and achievements by different funding mechanisms – a 
functionality critical to effectively respond to funder requirements. The URS is fully 
interoperable with DHIS and other databases used by ICAP country programs, whether they 
are developed in house or by host governments, allowing smooth data exchange. Automated 
consistency checks flag potential errors, ensuring that high-quality data are submitted. The 
URS also provides ‘real-time’ data feedback in graphical and tabular formats via dashboards 
that display data at the country, sub-national, and health-facility levels. Dashboards can be 
organized by programmatic areas and priority indicators, and can be stratified by time and 
geographic regions. It also has an on-line mapper that allows users to view data spatially and 
create user-defined maps. Figure 1 shows the URS mapper showing performance of a 
specific Priority Indicator in two provinces of Mozambique. Coverage of multidrug 
regimens for PMTCT of HIV amongst HIV-positive pregnant women is spatially 
represented, with each dot representing a health facility, and the size of the dot representing 
performance for the quarter. ICAP field staff use the URS to identify and track quality 
challenges, as well as to access aggregate data and to generate reports.
Standards of care
Although the 21 Priority Indicators are used to track program quality, some Core 
Interventions have no corresponding PEPFAR indicators (e.g., linkage to care), and some 
may require a more granular evaluation of facility performance (e.g. determination of 
infants’ HIV status). In these cases, ICAP has developed ‘SOC’ indicators, which combine 
additional indicators with performance standards. There are 18 priority SOCs. Unlike the 
Priority Indicators, SOCs often require manual data collection from patient charts and are 
generally collected from a small subset of patients at selected health facilities. Figure 2 
shows two Core Interventions, with corresponding priority PEPFAR indicators and priority 
SOC indicators. ICAP color-codes performance on SOC indicators for easy interpretation; 
performance that falls into a red zone requires immediate attention, whereas ‘yellow’ 
indicators can be addressed with slightly less urgency, and green zone performance 
corresponds to high quality of care.
ICAP country teams are encouraged to select Core Interventions that require more attention 
due to MoH priorities and/or performance challenges, and to assess relevant SOC indicators 
as needed. Decisions regarding which SOC indicators to prioritize are made judiciously, 
based on context and national priorities, recognizing the additional effort required to 
measure program performance above and beyond routinely collected PEPFAR indicators. 
The concept of targeted, in-depth assessment of quality using a standardized approach has 
been well received by the MoH with whom ICAP collaborates. In Mozambique, ICAP’s 
SOC work substantially contributed to the development of a ‘National Quality Improvement 
Initiative’ (Iniciativa de Melhoria de Qualidade) developed by the MoH and partners [6].
Standards of Care are measured manually during supportive supervision visits, by reviewing 
facility-based records (patient cards and/or registers) for a sample (e.g. 10%) of eligible 
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patients. ICAP Clinical and M&E Advisors work closely with facility-level providers to 
collect and analyze data, and to develop action plans to address deficiencies. Standard 
operating procedures, as well as data collection tools and facility feedback forms, have been 
developed to streamline this process. SOC measurement, although only assessed on subsets 
of patients, is useful for identifying gaps in the quality of care when relevant routinely 
collected data are not available, and offers an opportunity to engage clinic providers in the 
quality assurance process and provide immediate feedback on program performance.
Facility surveys (PFaCTS)
While routine indicators, Priority Indicators, and SOC indicators describe program 
performance, they provide minimal information about the context in which ICAP-supported 
programs operate. As context can impact performance, it is critical to collect this 
information regularly. Often, contextual information helps to explain poor performance and 
to focus activities to address gaps. To this end, ICAP conducts periodic facility surveys at all 
supported HIV care and treatment facilities and laboratories. The Program and Facilities 
Characteristics Tracking System (PFaCTS) assessment collects information on the facility 
type and context, staffing structure, data systems, available services, and tests. Survey results 
are used to assess whether the Core Interventions are available at ICAP-supported health 
facilities, and whether there are any major gaps. For example, power outages and stock-outs 
that could cause disruption to services, availability of CD4+ T-cell testing to assess ART 
eligibility and monitor treatment response, availability of family planning services to prevent 
unintended pregnancies in women with HIV infection, availability of psychosocial support 
services and provision of isoniazid preventive therapy (IPT) can be tracked using the facility 
survey tool. Importantly, PFaCTS assesses availability of interventions, but does not measure 
the degree of coverage among eligible patients.
Aggregation, interpretation, and use of data to support quality
ICAP uses several different approaches and platforms to communicate outcomes and 
priorities at headquarters, country offices, sub-national offices, and health facilities. At each 
level, ICAP staff critically examine routine, priority, and SOC indicators to identify quality 
challenges and to inform corrective action when needed. To reduce manual work as much as 
possible, the URS as well as the country databases contain online and dynamic dashboards 
and data query modules that help track progress towards targets using data visualizations, as 
described above. The dashboards enable ICAP staff to drill down from country to 
subnational to facility levels, and to compare trends across these units and time to allow 
users to visually identify areas that are falling short of certain targets.
ICAP Clinical and M&E Advisors share facility-level data with facility staff on a regular 
basis. Quarterly data are reviewed during supportive supervision visits, and wall charts 
showing performance against targets are created and displayed at health facilities to facilitate 
discussion and strategic planning. Regular data review meetings are also held between 
Clinical and M&E teams to inform supportive supervision strategies.
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A case study from Kenya illustrates the results of this approach to quality assurance. In 
2006, ICAP initiated direct support for HIV care and treatment services at four health 
facilities in Kenya. Over the ensuing years, ICAP in Kenya has expanded its support to 398 
health facilities offering HIV prevention, care, and treatment, TB diagnosis and treatment, 
and HIV testing and counseling services, as well as to an additional 755 facilities offering 
PMTCT services. These facilities include referral hospitals, county hospitals, and sub-
district hospitals, spread over a geographic area of roughly 42 929 km2, across five 
administrative counties. As of September 2014, 787 470 clients had cumulatively been tested 
for HIV; 277 711 had enrolled in HIV care; and 150 293 had initiated ART. ICAP in Kenya 
supports the ‘Three Ones’ principle – one national HIV action framework, one national 
AIDS coordinating authority, and one national M&E system – and provides technical 
assistance and hands-on support for the national HIV program database using DHIS2. Figure 
3 illustrates the support provided for routine data collection by ICAP in Kenya.
ICAP M&E officers assist facilities to prepare monthly MoH reports, which are due by the 
fifth day of each month. As each M&E officer supports 13–21 facilities, and it takes between 
20 min to 4 h to travel from facility to facility on rural roads, it is not possible to be 
physically present at each facility to assist staff in preparing all the required reports. Instead, 
ICAP M&E officers prioritize visits to high-volume facilities with a history of data quality 
challenges to assist them in preparing the MoH reports. By the second week of the month, 
the M&E officers move on to the sub-county health offices where they obtain draft facility-
level MoH data from sub-county health records and information officers.
M&E officers review the reports from their assigned health facilities and conduct a data 
variance analysis. Here, facilities with notable variations in key indicators (greater than 
±10% change from previous report) are flagged and prioritized for more in-depth DQA. 
During these in-depth DQAs, M&E officers return to the targeted facilities and re-tally the 
data together with the facility staff. Observed discrepancies are immediately corrected, and 
the revised MoH report is shared with the sCHRIOs. All completed and verified facility-
level MoH monthly reports without discrepancies are keyed into the national DHIS2 
database by the 15th of each month, and are available to all stakeholders countrywide.
After the 15th of each month, ICAP regional data management teams download the required 
MoH data from DHIS2 into the regional ICAP aggregate database. Here, further checks on 
data trends are conducted to ensure that reports are consistent across time, and that no 
obvious data transcription errors occurred as the data were transferred from paper to 
electronic records at the sub-county level. Thereafter, data are transmitted to the ICAP 
Kenya central office, where the M&E Unit checks performance against the ICAP Priority 
Indicators. Facilities that have underperformed are flagged and discussed with the ICAP 
Clinical Advisors, enabling them to better target support. Finally, clean data are uploaded to 
the URS.
Fostering demand for data and the routine use of data for decision-making is an important 
step towards creating a culture of quality in health systems. To facilitate data consumption at 
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the facility level, the ICAP M&E team generates standard charts that serve as routine 
quarterly feedback reports, showcasing the performance of each supported facility by quarter 
over the span of two years. These charts are mounted strategically at relevant service 
delivery points within the facility, as illustrated in Fig. 4. ICAP M&E officers use these wall 
charts and graphs to generate discussion, which often identifies poorly understood or 
problematic indicators that can be addressed during their routine mentorship visits. The data 
are also reviewed at multidisciplinary team meetings, enabling different facility-level 
providers to contribute to problem-solving and quality improvement activities.
Discussion
Monitoring program quality across a large and heterogeneous program in multiple resource-
limited countries requires an overall quality framework and carefully targeted data 
collection, cognizant of the constraints of working within weak health systems with limited 
human resources and largely paper-based data systems. A parsimonious and efficient 
approach to data collection requires programs to leverage existing routinely collected data as 
much as possible, while also developing additional indicators that can be used for targeted, 
in-depth quality assessment. Equally critical are investments in electronic systems with 
automated processes, as well as human resources to support aggregation, verification, 
dissemination, and utilization of hundreds of thousands of data points every quarter to 
support data-driven decisions for program quality improvement.
The strength of the ICAP quality assurance model is its ability to leverage innovation, 
technology, and on-the ground presence to support national M&E systems. ICAP’s approach 
has been designed to align with national systems and to strengthen the culture of data 
verification, data review, and data use to enhance program quality. These quality assurance 
systems also provide the foundation for quality improvement initiatives, which are critical 
elements of ongoing program improvement.
While the intent is to build sustainable local capacity, enabling ICAP’s support to be 
transferred to District Health Management Teams and other local partners over time, this has 
not yet happened in all countries. In some contexts, despite continual efforts to build M&E 
capacity, high staff turnover at the facility and sub-national levels can combine with ICAP’s 
availability, expertise, and hands-on approach to create dependency on ICAP staff for 
routine M&E activities. Although this is uncommon in more mature national HIV programs, 
there are some contexts in which M&E remains largely dependent on external support.
ICAP’s experience suggests the need for robust investment in quality assurance and M&E 
by both national governments and external donors in order to effectively implement and 
monitor large and complex public health initiatives, such as national HIV programs. 
Investments in well designed electronic data management systems, pre-service education, in-
service training, and supportive supervision in quality assurance and M&E, as well as 
inclusion and capacity building of key cadres such as data entry staff and M&E managers 
within the national health systems, is critical to ensure routine collection, aggregation, and 
review of program performance data.
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Fig. 1. URS mapper showing performance of a specific Priority Indicator in two provinces of 
Mozambique
URS, Unified Reporting System.
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Fig. 2. Examples of Priority Indicators and Standards of Care Indicators for selected core 
interventions
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Fig. 3. Support for Routine Data Collection at ICAP in Kenya. HCWs, Health care workers
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Fig. 4. Wall chart in use at Machakos District Hospital in Eastern Province of Kenya
The wall chart tracks retention on ART by ART initiation year. The X-axis represents 
different cohorts of ART patients by the year they initiated ART. The Y-axis represents % 
retained of all patients initiated on ART in that year. The green bar represents retention by 
January 2013, while the red bar represents retention by January 2014. ART, antiretroviral 
therapy.
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HIV testing and counselling Includes provider-initiated testing and counseling (PITC) and testing for partners and
  family members
Linkage to HIV care for those testing positive for 
HIV
Linkage from all HIV testing entry points
Cotrimoxazole (CTX) prophylaxis CTX prophylaxis for all eligible people living with HIV (PLWH)
Tuberculosis screening Regular screening with a symptom-based checklist
Additional evaluation and treatment for those who screen positive
Isoniazid preventive therapy (IPT) for those who screen negative
Assessment of ART eligibility, with prompt ART
  initiation, if eligible
WHO staging at every visit, including assessment and treatment of opportunistic
  illnesses
Monitoring of child growth and development
CD4+ testing at enrollment in care and every 6 months thereafter
Prevention of mother-to-child transmission of HIV Family planning services to prevent unintended pregnancy
ART for all pregnant and breastfeeding women with HIV
Prompt provision of antiretroviral and other prophylaxis at birth
Ongoing care for HIV-infected mothers and HIV-exposed infants
Medication monitoring and management Monitoring of medication adherence & provision of adherence support
Monitoring for and management of medication-related side effects and toxicity
Monitoring for treatment response and treatment failure, with regimen adjustment, as
  needed
Monitoring and supporting retention in HIV care Appointment reminders
Monitoring of appointment attendance
Community-based patient groups for ART refills
Outreach and tracking of those who miss appointments and/or are lost to follow-up
Access to laboratory testing for HIV diagnosis,
  determining ART eligibility, monitoring treatment
  response, and diagnosing TB
HIV diagnosis including rapid HIV testing and dried blood spot-based HIV-1 DNA 
PCR
  for early infant diagnosis
CD4+ T-cell testing for assessing ART eligibility and monitoring treatment response
Routine or targeted viral load monitoring to detect treatment failure, if available
Microscopic or molecular TB diagnosis
Psychosocial support Patient education
Counseling to support disclosure, manage stigma and discrimination
Support groups
Financial support and microfinance projects
ART, antiretroviral therapy; TB, tuberculosis.
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Table 2
Sample Priority Indicators and ICAP minimum targets.
95% of patients in HIV care and treatment receive cotrimoxazole
  (CTX) prophylaxis
90% of patients still alive and on treatment 12 months after initiating
  ART
95% of patients in HIV care and treatment screened for TB at their last
  clinical visit
95% of HIV positive pregnant women receive multidrug antiretrovirals
  (including ART) in ANC to reduce MTCT
ANC, antenatal case; ART, antiretroviral therapy; MTCT, mother-to-child transmission; TB, tuberculosis.
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